Clinical trial
Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients
NCT00184951 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00184951 |
|---|---|
| Title | Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients |
| Official title | Pharmacodynamics and Pharmacokinetics of Combined Use of Rosuvastatin (Crestor) and Lopinavir/Ritonavir (Kaletra) in HIV-infected Patients With Hyperlipidemia (ROSALKA) |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | Abbott Industry AstraZeneca |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Rosuvastatin |
| Enrollment | 30 |
| Start date | Apr 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 12, 2020 |
| Countries | Germany, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: